… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being … SARS-CoV and
other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 …

… coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2… , and their potential implications for SARS-CoV-2 infection. At …

… VeroE6/TMPRSS2 cells are superior to other cell lines tested in this study for SARS-CoV-2
isolation. Consistent with previous reports (2, 4), the amount of SARS-CoV-2 RNAs in the …

… MERS-CoV), and other coronavirus has been difficult to create due to vaccine induced
enhanced … Multiple betacoronaviruses including SARS-CoV-2 and SARS-CoV-1 expand cellular …

… Antibody-dependent enhancement (ADE) of infection is … coronavirus 2 (SARS-CoV-2)
infection has also been discussed since the beginning of the coronavirus disease 2019 (COVID-19…

… in SARS-CoV-2 should be urgently resolved using experimental immunology. For example,
measuring cross-reactivity of antibodies of unexposed individuals to SARS-CoV-2 could …

… to SARS-CoV-2 in a cohort of 149 convalescent individuals after diagnosis with COVID-19.
IgA … Plasma IgA monomers specific to SARS-CoV-2 proteins were demonstrated to be twofold …

… of enhancing antibodies using authentic SARS-CoV-2 virus. The replication of the authentic
SARS-CoV-2 … more than four times in the presence of enhancing antibodies (Figure 3C). …

… However, using monkey and mouse models of SARS-CoV-2 infection, none of the in vitro
infection-enhancing Abs enhanced SARS-CoV-2 virus replication or infectious virus in the lung …

… Following previous observations made with human immune cell lines,2 we determined
whether ADE of SARS-CoV infection could occur also in primary human immune cells. To …